(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

RECEPTORES DE ANTÍGENO QUIMÉRICO ANTI-CLDN E MÉTODOS DE USO

ArquivadaInvention PatentPCT · US2015059106

Application data

Number

112017009517

Type

Invention Patent

Filing

11/04/2015

Publication

12/19/2017

PCT

US2015059106

Progress at the INPI

  1. Filing11/04/15
  2. Publication12/19/17
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/04/2015 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/05/2019. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ABBVIE STEMCENTRX LLC

US

See this company's full portfolio

Inventors

D. L. (pessoa física)

US

P. E. (pessoa física)

US

R. S. (pessoa física)

US

S. D. (pessoa física)

US

Technical data

Priority claims

US

62/157,928 · 05/06/2015

US

62/247,108 · 10/27/2015

US

PCT/US2014/064165 · 11/05/2014

Abstract

RESUMO?RECEPTORES DE ANTÍGENO QUIMÉRICO ANTI-CLDN E MÉTODOS DE USO?Trata-se de receptores de antígeno quimérico anti-CLDN inovadores e métodos para utilização dos mesmos para tratar distúrbios proliferativos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

02/05/2019

RPI 2509

Arquivamento - Art. 33 da LPI

#11.1

11/21/2018

RPI 2498

Notificação de entrada na fase nacional - PCT

#1.3

12/19/2017

RPI 2450

Alteração de dados cadastrais

#1.1

05/30/2017

RPI 2421

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.